MEDADVISOR LIMITED |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.31 AUD | +1.64% |
|
+5.08% | +44.19% |
| Apr. 24 | MedAdvisor Operating Revenue Rises 42% to AU$24.2 Million in March Quarter | MT |
| Apr. 23 | MedAdvisor's Gross Profit Climbs 48.5% in Fiscal Q3, Revenue Rises 42.4% | MT |
Evolution of the average Target Price on MedAdvisor Limited
Price target over the last 5 years
History of analyst recommendation changes
3ad126fd9a6f376ff62.sh8iyBHfIQfih16ifvJWZB1TH5beuTpBD2swtWX0cXw.0GZSqnrmVTOy8W7WDbw7AlJmfOfn1X4sZw5E5xSHOwTYclqXeokVTpLAEw~a2a4864664f61b8e46f876a584e12707
Analysts' Consensus
Sell
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
0.31
AUD
Average target price
0.4233
AUD
Spread / Average Target
+36.56%
High Price Target
0.47
AUD
Spread / Highest target
+51.61%
Low Price Target
0.39
AUD
Spread / Lowest Target
+25.81%
Consensus detail
Consensus revision (last 18 months)
Trading Rating
Investor Rating
ESG Refinitiv
EPS Revisions
- Stock Market
- Equities
- MDR Stock
- Consensus MedAdvisor Limited
